This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ABT-652
AbbVie Inc.
Drug Names(s): ABT-652
Description: ABT-652 targets the histamine 3 receptor (H3).
ABT-652 News
Additional information available to subscribers only:
- Targets
- Routes
- Catalysts
- Designations
- Events
Request a Free Demo Subscriber Login Search for another drug